# MIAPE Guidelines Explained: What to Include in Your Proteomics Experiment Reporting for Reproducibility The Minimum Information About a Proteomics Experiment (MIAPE) guidelines define the essential metadata and methodological details that must accompany a proteomics experiment for it to be critically evaluated and potentially reproduced by other laboratories. Developed by the Human Proteome Organization's Proteomics Standards Initiative (HUPO-PSI), MIAPE modules cover sample preparation, separation techniques, mass spectrometry, and data processing. For researchers preparing manuscripts, database submissions, or supplementary information, following MIAPE ensures that another laboratory can understand exactly what was done, assess the quality of the work, and recreate the experiment if needed. This article explains each MIAPE module, provides a practical checklist of required information, and describes common reporting failures with concrete solutions. ## The Purpose and Structure of MIAPE Guidelines The HUPO-PSI was established to address a growing problem in proteomics research: experiments were being published with insufficient methodological detail to allow replication or independent assessment. As protocols increased in complexity and technology diversified, the need for standardized reporting became urgent. The MIAPE specification was created as a set of reporting guidelines that specify the appropriate level of detail for describing the various components of a proteomics experiment. The first modules were finalized in 2006, and the specification continues to evolve alongside new technologies and data types. MIAPE operates on a modular principle. Instead of a single monolithic document, the guidelines are organized into separate modules, each addressing a distinct aspect of the experimental workflow. This modular structure allows researchers to report only the modules relevant to their specific experiment. A gel-based study requires the gel electrophoresis module, while a liquid chromatography mass spectrometry study requires the mass spectrometry module. Quantitative studies require the MIAPE Quant module, which was developed in parallel with the mzQuantML data exchange format. The core principle underlying all MIAPE modules is that the reported information must describe the complete experiment, including both experimental protocols and data processing methods. This allows a critical evaluation of the whole process and the potential recreation of the work. The guidelines were developed with input from a broad spectrum of stakeholders in the proteomics field, representing a consensus view of the most important data types and metadata required for a quantitative experiment to be analyzed critically or a data analysis pipeline to be reproduced. The development process for MIAPE modules followed established principles that considered the needs of different stakeholder groups. Experimentalists need clear guidance on what to report without excessive burden. Funders and publishers need assurance that the research they support or disseminate meets minimum quality standards. The private sector, including instrument and software vendors, needs to understand how their products fit into the reporting ecosystem. The guidelines were designed to address the overlap with other reporting guidelines in related fields while maintaining a specific focus on proteomics techniques. ## At a Glance: MIAPE Module Overview | MIAPE Module | Experiment Stage Covered | Key Information Required | Typical Use Case | | --- | --- | --- | --- | | Sample Preparation | Protein extraction, digestion, labeling | Source material, lysis buffer, protease inhibitors, digestion enzyme, labeling reagents | All proteomics experiments | | Gel Electrophoresis | 1D or 2D protein separation | Gel type, percentage, running buffer, staining method, image acquisition settings | Gel-based proteomics, differential display studies | | Mass Spectrometry | Instrument acquisition | Instrument model, ionization source, mass analyzer settings, scan parameters | All mass spectrometry based experiments | | MIAPE Quant | Quantitative analysis | Quantification strategy, labeling or label-free approach, statistical methods | Quantitative proteomics, SRM studies | | Data Processing | Bioinformatics analysis | Search engine, database version, search parameters, false discovery rate control | Protein identification and quantification workflows | The modular structure means that a typical experiment will require multiple modules. A quantitative liquid chromatography mass spectrometry experiment, for example, requires the sample preparation module, the mass spectrometry module, the MIAPE Quant module, and the data processing module. Each module contributes the information needed to describe one stage of the workflow, and together they provide a complete picture of the experiment. ## Sample Preparation Reporting Requirements The sample preparation module requires detailed description of how proteins were extracted, processed, and prepared for analysis. This information is critical because variations in sample handling can introduce substantial bias and affect the final results. A researcher attempting to reproduce an experiment needs to know the exact conditions under which the sample was collected, stored, and processed. ### Source Material and Biological Context The report must specify the biological source of the sample, including the organism, tissue type, cell line, or biofluid. For clinical samples, relevant patient information that does not compromise privacy should be included. The developmental stage, treatment conditions, or disease state of the biological material must be documented. Storage conditions before processing, including temperature and duration, should be reported because protein degradation can occur during prolonged storage. The choice of biological material has direct consequences for downstream analysis. Different tissues and cell types have different protein complexity and dynamic range, which affects the depth of coverage achievable and the suitability of different separation strategies. The report should also indicate whether the sample was pooled from multiple biological sources or derived from a single source, as pooling affects biological variability and the interpretation of quantitative results. ### Lysis and Extraction Conditions The lysis buffer composition must be described in detail, including the detergent type and concentration, salt concentration, pH, and any reducing agents. Protease inhibitors are essential for preventing protein degradation during extraction, and their presence and concentration must be reported. The lysis method, whether mechanical disruption, sonication, freeze-thaw cycling, or chemical lysis, should be specified. Temperature and duration of the lysis procedure affect protein yield and integrity. Different lysis methods produce different results depending on the sample type. Mechanical disruption methods such as bead beating or homogenization are effective for tough tissues but generate heat that can denature proteins. Sonication is efficient but can cause sample heating and foaming. Chemical lysis using detergents is gentler but may not be effective for all sample types. The choice of method should be justified in the report, and the specific conditions used must be documented. ### Protein Quantification and Quality Assessment The method used to determine protein concentration must be reported, including the assay type and the standard used for calibration. Common assays include Bradford, BCA, or Lowry methods, each with different compatibility profiles with detergents and reducing agents. Quality assessment steps, such as SDS-PAGE visualization or spectrophotometric analysis, should be documented. The amount of protein used for downstream processing is a critical parameter that must be stated. The choice of quantification assay affects the accuracy of the protein concentration measurement. The Bradford assay is compatible with many detergents but is affected by basic proteins and can underestimate protein concentration. The BCA assay is more tolerant of detergents but is affected by reducing agents. The Lowry method is sensitive but has more interfering substances. The report should indicate which assay was used and how the assay was calibrated. ### Digestion Protocol For bottom-up proteomics, the digestion enzyme must be specified, typically trypsin but potentially other proteases. The enzyme to protein ratio, digestion temperature, and incubation time affect digestion efficiency and peptide recovery. Any reduction and alkylation steps must be described, including the reagents used and their concentrations. The quenching method used to stop digestion should also be reported. Digestion efficiency directly affects the quality of the downstream analysis. Incomplete digestion produces missed cleavages that complicate peptide identification and quantification. Overdigestion can produce non-specific cleavage products. The enzyme to protein ratio and incubation time must be optimized for the specific sample type and reported accurately. The use of digestion enhancers such as urea or organic solvents should also be documented. ### Labeling and Derivatization For quantitative experiments using chemical labeling, the specific labeling reagents must be identified. This includes isobaric tags such as TMT or iTRAQ, or metabolic labeling approaches such as SILAC. The labeling protocol, including reagent amounts, incubation conditions, and any quenching steps, must be described. The number of channels or labels used in the experiment should be stated. Labeling efficiency is a critical factor in quantitative accuracy. Incomplete labeling produces peptides that are not quantified or are quantified incorrectly. The report should indicate how labeling efficiency was assessed and what level of efficiency was achieved. For metabolic labeling, the number of cell doublings in labeled medium and the incorporation rate should be reported. ## Gel Electrophoresis Reporting Requirements The gel electrophoresis module covers both one-dimensional and two-dimensional separation techniques. Gel-based approaches remain important in proteomics for protein-level separation, differential display analysis, and preparation of protein fractions for downstream mass spectrometry analysis. ### One-Dimensional Electrophoresis For one-dimensional SDS-PAGE, the report must specify the gel percentage or gradient range, the gel dimensions, and the buffer system used. The sample loading amount and volume must be stated. The running conditions, including voltage, current, and duration, affect separation quality and must be documented. The staining method, whether Coomassie, silver, or fluorescent staining, and the image acquisition settings must be reported. ### Two-Dimensional Electrophoresis For two-dimensional electrophoresis, additional information is required. The isoelectric focusing conditions, including the pH gradient range, strip length, focusing time, and voltage program, must be described. The equilibration steps between the first and second dimensions must be documented. The second dimension conditions, including gel percentage and running parameters, must be reported. The protein detection and image analysis methods must be specified. ### Image Acquisition and Analysis The image acquisition system and settings must be described, including the scanner model, resolution, and dynamic range. Any image processing steps, such as background subtraction or spot detection parameters, must be documented. The software used for spot matching and quantification must be identified, including the version number. The criteria for defining differentially expressed spots must be stated. ## Mass Spectrometry Reporting Requirements The mass spectrometry module requires comprehensive description of the instrument and acquisition parameters. Mass spectrometry is a well-established protein identification tool, and recent methodological and technological developments have made possible the extraction of quantitative data of protein abundance in large-scale studies. The instrument settings directly influence the quality and type of data generated, making their documentation essential for reproducibility. ### Instrument Configuration The mass spectrometer model and manufacturer must be identified. The ionization source, whether electrospray ionization (ESI) or matrix-assisted laser desorption ionization (MALDI), must be specified. The mass analyzer type, such as quadrupole, time-of-flight, ion trap, or Orbitrap, and any hybrid configurations must be described. The resolution settings for both precursor and fragment ion scans should be reported. The instrument configuration determines the type of data that can be acquired and the quality of the measurements. High-resolution instruments can distinguish closely spaced peaks and provide accurate mass measurements, while low-resolution instruments may not resolve complex mixtures. The report should indicate the instrument capabilities and how they were used in the experiment. ### Acquisition Parameters The data acquisition mode must be specified, including whether the instrument operated in data-dependent acquisition (DDA) or data-independent acquisition (DIA) mode. For DDA, the criteria for precursor selection, including intensity thresholds and charge state selection, must be described. The number of precursor ions selected per cycle and the dynamic exclusion settings affect the depth of coverage. For DIA, the isolation window width and the m/z range covered must be reported. The acquisition parameters directly affect the number of peptides identified and the reproducibility of the measurements. In DDA mode, the intensity threshold determines which precursor ions are selected for fragmentation, and the dynamic exclusion settings determine how often the same precursor can be selected. In DIA mode, the isolation window width determines the complexity of the fragment ion spectra and the specificity of the quantification. ### Chromatography Conditions The liquid chromatography system and column specifications must be described, including column dimensions, particle size, and stationary phase chemistry. The mobile phase composition, gradient duration, and flow rate directly affect peptide separation and must be reported. The injection volume and sample loading amount are critical parameters. Column temperature, if controlled, should be stated. Chromatography conditions affect the separation quality and the reproducibility of retention times. The column chemistry determines the selectivity of the separation, while the gradient duration determines the peak capacity and the analysis time. The report should indicate whether the chromatography system was operated in a standard configuration or whether any modifications were made. ### Targeted Acquisition For targeted approaches such as Selected Reaction Monitoring (SRM), additional parameters must be reported. The transitions monitored, including precursor ion m/z and fragment ion m/z values, must be listed. Collision energy settings and dwell times for each transition should be documented. The internal standards used for quantification, including their concentrations and origin, must be specified. Targeted approaches require careful optimization of the acquisition parameters for each analyte. The choice of transitions affects the specificity and sensitivity of the measurement. The report should indicate how the transitions were selected and validated, and whether any interference testing was performed. ## Data Processing and Bioinformatics Reporting The data processing module covers the computational steps that convert raw mass spectrometry data into identified and quantified proteins. These steps have a substantial impact on the final results, and different analysis pipelines can produce different outcomes from the same raw data. The MIAPE guidelines require sufficient detail about data processing to allow the analysis to be reproduced. ### Raw Data Conversion and Processing The software used to convert raw instrument files into peak lists or other intermediate formats must be identified, including the version number. Any peak picking, smoothing, or deisotoping steps should be described. The parameters used for these processing steps, such as signal-to-noise thresholds, must be reported. The conversion of raw data into peak lists is a critical step that can introduce variability. Different peak picking algorithms and parameter settings can produce different peak lists from the same raw data. The report should indicate the software and version used for conversion and the specific parameters applied. ### Database Searching The search engine used for peptide identification must be specified, including the version number. The protein sequence database searched must be identified, including the database name, version or release date, and the number of entries. The taxonomy filter applied, if any, should be stated. Search parameters including enzyme specificity, number of missed cleavages allowed, fixed and variable modifications, precursor mass tolerance, and fragment mass tolerance must all be reported. The choice of search engine and database has a substantial impact on the identification results. Different search engines use different scoring algorithms and may identify different sets of peptides from the same data. The database version is critical because protein databases are updated regularly, and the version used affects the results. A search against an older version of a database may produce different identifications than a search against the current version. ### False Discovery Rate Control The method used to estimate and control the false discovery rate (FDR) must be described. This typically involves the use of a decoy database, and the strategy for constructing decoys should be stated. The target FDR threshold applied at the peptide and protein levels must be reported. The method for calculating FDR, whether using a target-decoy approach or a model-based approach, should be specified. FDR control is essential for ensuring the reliability of the identification results. The target-decoy approach is the most common method, where decoy sequences are added to the database to estimate the number of false positives. The report should indicate how the decoy database was constructed and how the FDR was calculated. ### Protein Inference and Quantification The software and method used to assemble peptides into protein identifications must be described. The parsimony principle or other protein inference rules applied should be stated. For quantitative analysis, the method used to calculate peptide and protein abundances must be reported. This includes the quantification approach, whether label-based or label-free, and the specific algorithm used. Normalization methods applied to the data must be described. Protein inference is complicated by the presence of shared peptides that map to multiple proteins. The parsimony principle assigns shared peptides to the minimum number of proteins that can explain the observed peptides. The report should indicate how shared peptides were handled and how protein groups were defined. ### Statistical Analysis The statistical methods used to identify differentially abundant proteins must be specified. The software package and version used for statistical analysis should be identified. The statistical test applied, the multiple testing correction method, and the significance thresholds must be reported. Any imputation methods used for missing values should be described. The choice of statistical methods affects the identification of differentially abundant proteins. Different tests make different assumptions about the data distribution and variance structure. The report should indicate whether the data were transformed before analysis and how the assumptions of the statistical tests were assessed. ## MIAPE Quant: Reporting Quantitative Experiments The MIAPE Quant guidelines were developed specifically for quantitative mass spectrometry based experiments. These guidelines describe the minimum information to be reported when a quantitative data set derived from mass spectrometry is submitted to a database or as supplementary information to a journal. Several strategies for absolute and relative quantitative proteomics are possible, each having specific measurements and therefore different data analysis workflows. ### Quantification Strategy The overall quantification strategy must be clearly stated. This includes whether the experiment used labeled or label-free approaches. For labeled approaches, the specific labeling method must be identified, whether metabolic labeling, chemical labeling, or enzymatic labeling. For label-free approaches, the quantification basis must be specified, whether spectral counting or precursor ion intensity measurement. The choice of quantification strategy determines the type of measurements that are made and the data analysis workflow that is required. Labeled approaches provide relative quantification within a single experiment, while label-free approaches compare measurements across separate experiments. The report should indicate the rationale for the chosen strategy and its limitations. ### Experimental Design The experimental design must be described, including the number of biological replicates and technical replicates. The randomization and blocking strategies used should be stated. The order of sample acquisition should be reported, particularly for label-free experiments where batch effects can influence results. Any quality control samples included in the run should be described. The experimental design determines the statistical power of the study and the conclusions that can be drawn. Biological replicates capture the natural variability between samples, while technical replicates capture the variability of the measurement process. The report should indicate how the sample size was determined and whether a power analysis was performed. ### Quantification Measurements The specific measurements used for quantification must be reported. For labeled approaches, the reporter ion intensities or precursor ion intensities must be described. For label-free approaches, the peak areas or spectral counts must be specified. The software used to extract these measurements must be identified. Any filtering criteria applied to the quantitative data, such as minimum peptide count or coefficient of variation thresholds, must be reported. The quality of the quantitative measurements depends on the extraction method and the filtering criteria applied. Low-quality measurements can introduce noise and bias into the analysis. The report should indicate how the quality of the quantitative measurements was assessed and what criteria were used to retain or discard measurements. ### Data Normalization The normalization method applied to the quantitative data must be described. Common approaches include median normalization, quantile normalization, or normalization to reference proteins. The rationale for the chosen normalization method should be stated. Any batch effect correction methods applied must be reported. Normalization is essential for removing systematic bias from the quantitative data. Different normalization methods make different assumptions about the data and can produce different results. The report should indicate how the normalization method was selected and whether the assumptions of the method were assessed. ### Statistical Assessment The statistical methods used to assess the significance of quantitative changes must be described. The specific statistical test applied, whether t-test, ANOVA, or non-parametric alternatives, must be stated. The multiple testing correction method used must be reported. The criteria for defining differentially abundant proteins, including fold change thresholds and adjusted p-values, must be specified. The statistical assessment determines which proteins are considered to change significantly between conditions. The choice of statistical test and the thresholds applied affect the balance between sensitivity and specificity. The report should indicate how the thresholds were selected and whether the results were validated. ## Practical Implementation: Generating MIAPE Compliant Reports Implementing MIAPE reporting in a laboratory workflow requires planning and the use of appropriate tools. Several bioinformatics resources can generate MIAPE compliant reports or check proteomics data files for MIAPE compliance. These tools reduce the burden of manual reporting and help ensure that no required information is omitted. ### Using Reporting Tools Web-based tools have been developed to help generate and store MIAPE compliant reports describing gel electrophoresis and mass spectrometry based experiments. These tools can be used during the reviewing phase of the proteomics publication process and can facilitate data interpretation through the comparison of related studies. Researchers should identify the reporting tool appropriate for their experiment type and integrate its use into their workflow. The use of reporting tools can substantially reduce the burden of MIAPE compliance. These tools provide structured templates that guide researchers through the reporting process and ensure that all required information is captured. Some tools also provide validation functions that check reports for completeness and flag missing information. ### Documentation During the Experiment The most effective approach to MIAPE compliance is to document experimental details as the experiment is performed instead of attempting to reconstruct them after the fact. Laboratory notebooks should include all parameters that will later be required for reporting. Instrument log files should be preserved, as they contain acquisition parameters that may not be manually recorded. Sample tracking systems should capture the provenance of each sample. Documentation during the experiment is more accurate and less burdensome than retrospective documentation. Parameters that are recorded at the time of the experiment are less likely to be forgotten or misremembered. The use of electronic laboratory notebooks and sample management systems can facilitate this documentation process. ### Data Repository Submission Many proteomics journals and databases require MIAPE compliant reporting as a condition of publication or data submission. The MIAPE guidelines have influenced or been directly adopted as part of journal guidelines. Researchers should check the specific requirements of their target journal or repository before submission. The data files submitted should be accompanied by the appropriate MIAPE module reports. Data repositories provide a permanent archive for proteomics data and facilitate data sharing and reuse. The submission process typically requires the data files and the associated metadata to be formatted according to the repository specifications. The MIAPE compliant reports can be used to generate the required metadata. ### Training and Standard Operating Procedures Laboratories should develop standard operating procedures that incorporate MIAPE requirements into routine workflows. New laboratory members should be trained on the reporting requirements before they begin generating data. Regular audits of completed experiments can identify gaps in documentation before they become problems at the publication stage. Training and standard operating procedures ensure that MIAPE compliance is maintained consistently across the laboratory. The training should cover the specific reporting requirements for the techniques used in the laboratory and the use of any reporting tools. The standard operating procedures should specify when and how documentation is completed. ## Records and Measurements for MIAPE Compliance Maintaining accurate records is essential for MIAPE compliant reporting. The following measurements and records should be captured for every proteomics experiment. ### Instrument Records Instrument serial numbers, firmware versions, and calibration records should be maintained. The date of the last calibration and the calibration standard used should be documented. Any instrument maintenance performed before or during the experiment should be recorded. These records help establish the instrument condition at the time of data acquisition. Instrument performance can change over time due to contamination, wear, and drift. Calibration records provide evidence that the instrument was performing within specification at the time of the experiment. Maintenance records document any interventions that may have affected instrument performance. ### Sample Tracking Records Each sample should have a unique identifier that links to its source, processing history, and analysis results. The date and time of each processing step should be recorded. Storage conditions and durations should be tracked. Any deviations from the standard protocol should be noted. Sample tracking is essential for maintaining the integrity of the experiment. The sample identifier provides a link between the biological source, the processing history, and the analytical results. Deviations from the standard protocol should be documented because they may affect the interpretation of the results. ### Data File Records Raw data files should be preserved in their original format. The file naming convention should be documented so that files can be traced to their corresponding samples. The software version used to acquire the data should be recorded. Any data conversion steps should be logged, including the software and version used for conversion. The preservation of raw data files is essential for data integrity and reanalysis. The raw files contain all the information acquired by the instrument and can be reanalyzed with different software or parameters. The file naming convention should be designed to prevent confusion and ensure traceability. ### Analysis Records The analysis workflow should be documented, including all software versions and parameters. The sequence of analysis steps should be recorded so that the analysis can be re-run if needed. The version of the protein database used for searching should be archived. Any custom scripts or workflows used for analysis should be version-controlled and preserved. The documentation of the analysis workflow is essential for reproducibility. The analysis should be re-runnable with the documented parameters and software versions. Custom scripts and workflows should be version-controlled to ensure that the exact version used for the analysis can be identified. ## Common Failure Patterns in MIAPE Reporting Several recurring problems appear when researchers submit proteomics data for publication or database deposition. Understanding these failure patterns can help researchers avoid them. ### Incomplete Instrument Parameter Reporting A common failure is reporting only the instrument model without the specific acquisition parameters. The instrument model alone is insufficient for reproduction because different settings on the same instrument can produce substantially different data. Researchers must report the specific settings used, including resolution, scan ranges, and activation methods. The instrument model identifies the hardware but not the configuration or the acquisition parameters. Two laboratories using the same instrument model may use different settings and produce different data. The report must include the specific settings used for the experiment. ### Missing Database Version Information Many reports identify the protein database searched but omit the version or release date. Protein databases are updated regularly, and the version used affects the results. A search against an older version of a database may produce different identifications than a search against the current version. The database version must be reported to allow exact reproduction. The protein database version is critical for reproducing the identification results. Database updates can add new sequences, remove obsolete sequences, and change sequence annotations. The report must identify the exact version of the database used for the search. ### Undocumented Data Processing Steps Researchers often describe the search engine used but omit the details of data processing before and after the search. Peak picking parameters, quality filters, and normalization steps all affect the final results. These steps must be documented to allow the complete analysis pipeline to be reproduced. The data processing steps between raw data acquisition and final results can have a substantial impact on the outcome. Different peak picking parameters can produce different peak lists, and different normalization methods can produce different quantitative results. The report must document all data processing steps. ### Vague Quantification Descriptions Quantitative experiments often lack sufficient detail about how abundances were calculated. The specific algorithm used for quantification, the normalization method, and the statistical approach must all be described. A statement that quantification was performed is insufficient without the specific parameters and methods. Quantification is a complex process with many steps, each of which can affect the final results. The report must describe the specific algorithm used for quantification, the normalization method applied, and the statistical approach used to assess significance. ### Omitted Sample Preparation Details Sample preparation is sometimes described briefly, omitting buffer compositions, incubation times, or enzyme amounts. These details are critical for reproduction because variations in sample preparation can introduce substantial bias. The complete sample preparation protocol must be reported. Sample preparation variations can introduce substantial bias into the results. Different lysis buffers can extract different subsets of the proteome, and different digestion conditions can produce different peptide mixtures. The report must include the complete sample preparation protocol. ## Limitations of MIAPE Guidelines While MIAPE guidelines provide a framework for reporting, they have limitations that researchers should understand. ### Scope of Coverage MIAPE modules cover specific aspects of proteomics experiments, but not all possible techniques and workflows have dedicated modules. Researchers using novel or emerging techniques may find that existing modules do not fully capture the relevant information. In these cases, researchers should report the information that is relevant to their specific approach, guided by the principles underlying MIAPE. The modular structure of MIAPE means that new modules can be added as new techniques emerge. However, there can be a lag between the adoption of a new technique and the development of a corresponding module. Researchers using novel techniques should report the information that is relevant to their approach, even if it does not fit neatly into an existing module. ### Focus on Description Instead of Quality MIAPE guidelines specify what information must be reported, but they do not prescribe how experiments should be performed. A MIAPE compliant report can describe a poorly designed or poorly executed experiment. The guidelines ensure that the methods are described, but they do not ensure that the methods are appropriate. Researchers and reviewers must still apply scientific judgment to assess experimental quality. The distinction between reporting and quality is important to understand. MIAPE compliance ensures that the methods are described in sufficient detail, but it does not guarantee that the methods are optimal or that the conclusions are valid. The scientific community must continue to assess the quality of the work through peer review and replication. ### Evolving Technology The MIAPE guidelines were developed for technologies that were current at the time of their creation. As new instrumentation and methods emerge, the guidelines may not immediately cover the relevant parameters. The HUPO-PSI continues to develop and update modules to address new technologies, but there can be a lag between technology adoption and guideline updates. The evolution of technology presents an ongoing challenge for reporting guidelines. New instruments and methods may have parameters that are not covered by existing modules. The HUPO-PSI works to update the guidelines, but researchers should be aware that the guidelines may not always be current. ### Implementation Burden Generating MIAPE compliant reports requires time and effort. The documentation burden can be substantial, particularly for laboratories that do not have established reporting workflows. However, the use of reporting tools and the integration of documentation into routine practice can reduce this burden. The implementation burden is a real consideration for laboratories, particularly those with limited resources. The use of reporting tools and the integration of documentation into routine practice can reduce the burden. The benefits of MIAPE compliance, including improved reproducibility and easier publication, generally outweigh the costs. ## Bioinformatics Resources for MIAPE Implementation Several bioinformatics resources can support the implementation of MIAPE compliant reporting in proteomics research. These resources provide training, tools, and workflows that facilitate the documentation and analysis of proteomics data. ### Training Resources The European Bioinformatics Institute offers training on data resources and practical analysis education for bioinformatics. These training programs cover the use of proteomics databases and analysis tools, including those relevant to MIAPE compliant reporting. The Galaxy Training Network provides accessible workflow training and analysis tutorials that cover proteomics data analysis and reproducibility. The Carpentries offers foundational computing and data training that can help researchers develop the skills needed for effective data reporting and analysis. Training is essential for building the skills needed for MIAPE compliant reporting. Researchers need to understand the reporting requirements and the tools available to support compliance. The training resources listed here provide a range of options for developing these skills. ### Workflow and Pipeline Resources The nf-core documentation describes community pipeline standards for reproducible bioinformatics workflows. These pipelines can be used for proteomics data analysis and provide a framework for reproducible analysis. The Bioconductor project provides packages and workflows for reproducible genomic and proteomic analysis, including tools for data processing, statistical analysis, and visualization. Workflow and pipeline resources can support MIAPE compliant reporting by providing standardized analysis procedures. The use of standardized workflows can reduce the variability introduced by different analysis approaches and facilitate the documentation of the analysis steps. ### Data Resources The National Center for Biotechnology Information provides access to databases, search systems, sequence resources, and analysis services that are relevant to proteomics research. These resources include protein sequence databases that are used for peptide identification and tools for sequence analysis. Data resources are essential for proteomics research and reporting. The protein sequence databases used for peptide identification must be identified in the report, including the version or release date. The NCBI resources provide access to these databases and associated tools. ## Professional Escalation Criteria Researchers should seek additional guidance or escalate reporting issues in specific situations. ### Journal or Repository Requirements If a target journal or data repository has specific reporting requirements that differ from or extend beyond MIAPE, researchers should consult the journal or repository guidelines directly. Some journals have adopted MIAPE or require specific data formats. The journal's instructions to authors should be reviewed before submission. Journal and repository requirements can vary substantially. Some journals have adopted MIAPE as a requirement, while others have their own specific requirements. Researchers should review the requirements of their target journal or repository before submission to ensure compliance. ### Unusual Experimental Designs Experiments that use novel techniques, unusual sample types, or non-standard workflows may require additional reporting beyond the standard MIAPE modules. In these cases, researchers should consult with colleagues who have experience with the specific technique or contact the journal editor for guidance. Unusual experimental designs may not fit neatly into the standard MIAPE modules. Researchers should seek guidance on how to report the relevant information for their specific approach. The journal editor can provide guidance on the reporting requirements for the specific experiment. ### Data Interpretation Difficulties If reviewers or collaborators have difficulty interpreting the reported data, this may indicate that the reporting is insufficient. Researchers should review their reports for completeness and consider whether additional details would aid interpretation. The MIAPE guidelines can serve as a checklist for identifying gaps. Difficulty in interpreting the reported data is a sign that the reporting may be insufficient. Researchers should review their reports against the MIAPE checklists and consider whether additional details would aid interpretation. The goal is to provide enough information for another laboratory to understand and reproduce the work. ### Software or Database Issues If the software used for analysis is no longer available or the database version is no longer accessible, researchers should document this limitation in their report. They should also consider whether the analysis can be reproduced with current software versions and note any differences in results. Software and database availability can change over time. If the software or database used for the analysis is no longer available, the reproducibility of the analysis may be compromised. Researchers should document this limitation and consider whether the analysis can be reproduced with current resources. ## Frequently Asked Questions ### What is the difference between MIAPE and other reporting guidelines? MIAPE is specific to proteomics experiments and was developed by the HUPO-PSI. Other reporting guidelines exist for other domains, such as genomics or metabolomics. MIAPE modules are designed to cover the specific techniques used in proteomics, including gel electrophoresis, mass spectrometry, and data processing. The guidelines are intended to complement, not replace, other reporting requirements from journals or funding agencies. ### Do I need to report all MIAPE modules for every experiment? No. MIAPE uses a modular structure, and researchers should report only the modules relevant to their experiment. A gel-based study requires the gel electrophoresis module, while a mass spectrometry based study requires the mass spectrometry module. Quantitative studies require the MIAPE Quant module. The principle is to report the information needed to describe the complete experiment. ### How do I know if my report is MIAPE compliant? Several bioinformatics resources can check proteomics data files for MIAPE compliance. These tools can identify missing information and help researchers generate compliant reports. Researchers can also manually review their reports against the MIAPE module checklists to identify gaps. The use of reporting tools during the reviewing phase of the publication process can facilitate compliance. ### What happens if I do not report MIAPE compliant information? Many proteomics journals and databases require MIAPE compliant reporting as a condition of publication or data submission. Manuscripts may be returned for additional information, or data submissions may be rejected. Even when not explicitly required, MIAPE compliant reporting improves the quality of the scientific record and allows other researchers to reproduce or build upon the work. ### How has MIAPE influenced journal policies? The MIAPE guidelines have influenced or been directly adopted as part of journal guidelines. Many proteomics journals now require authors to provide the minimum information specified by MIAPE when submitting manuscripts. Researchers should check the specific requirements of their target journal before submission to ensure compliance. ### What is the relationship between MIAPE and data formats like mzQuantML? MIAPE guidelines describe the minimum information to be reported, while data formats like mzQuantML provide a structured way to encode that information. The MIAPE Quant guidelines were developed in parallel with the mzQuantML data exchange format. Using structured data formats can facilitate MIAPE compliant reporting by ensuring that the required information is captured in a standardized way. ### How do I report experiments that use both labeled and label-free quantification? The MIAPE Quant guidelines are designed to describe a wide range of quantitative approaches, including labeled and label-free techniques and targeted approaches such as Selected Reaction Monitoring. For experiments that use multiple quantification strategies, each strategy should be described with the relevant information. The relationship between the different quantification approaches should be explained. ### Where can I find training on MIAPE compliant reporting? Bioinformatics training resources are available from organizations such as the European Bioinformatics Institute, which offers training on data resources and practical analysis education. The Galaxy Training Network provides accessible workflow training and analysis tutorials. The Carpentries offers foundational computing and data training. These resources can help researchers develop the skills needed for effective data reporting and analysis. ## Related Bioinformatics Guides - [Genomic Surveillance of SARS-CoV-2: Methods and Public Health Reporting](/knowledge/bioinformatics/genomic-surveillance-of-sars-cov-2-methods-and-public-health-reporting) - [Spatial Proteomics Methods: A Guide to Imaging Mass Cytometry, CODEX, and Other Techniques](/knowledge/bioinformatics/spatial-proteomics-methods-a-guide-to-imaging-mass-cytometry-codex-and-other-techniques) - [Digital Pathology Guidelines: A Reference for Implementation](/knowledge/bioinformatics/digital-pathology-guidelines-a-reference-for-implementation) - [Radiomics Feature Selection: Methods and Best Practices](/knowledge/bioinformatics/radiomics-feature-selection-methods-and-best-practices) - [Spatial Transcriptomics Methods: A Guide to Experimental Approaches](/knowledge/bioinformatics/spatial-transcriptomics-methods-a-guide-to-experimental-approaches) ## References and Further Reading - [NCBI Data Resources](https://www.ncbi.nlm.nih.gov/). National Center for Biotechnology Information. - [EMBL-EBI Training](https://www.ebi.ac.uk/training). European Bioinformatics Institute. - [Bioconductor](https://bioconductor.org/). Bioconductor Project. - [Galaxy Training Network](https://training.galaxyproject.org/). Galaxy Project. - [nf-core Documentation](https://nf-co.re/docs). nf-core. - [The Carpentries Lessons](https://carpentries.org/lessons). The Carpentries. - [Guidelines for reporting quantitative mass spectrometry based experiments in proteomics.](https://pubmed.ncbi.nlm.nih.gov/23500130). Journal of proteomics, 2013. - [Minimum reporting requirements for proteomics: a MIAPE primer.](https://pubmed.ncbi.nlm.nih.gov/17031795). Proteomics, 2006. - [The Minimal Information about a Proteomics Experiment (MIAPE) from the Proteomics Standards Initiative.](https://pubmed.ncbi.nlm.nih.gov/24136562). Methods in molecular biology (Clifton, N.J.), 2014. - [The minimum information about a proteomics experiment (MIAPE).](https://pubmed.ncbi.nlm.nih.gov/17687369). Nature biotechnology, 2007. - [Semi-automatic tool to describe, store and compare proteomics experiments based on MIAPE compliant reports.](https://pubmed.ncbi.nlm.nih.gov/20077409). Proteomics, 2010. > This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.